SchizophreniaNeuroimaging & Brain MeasuresHealthy VolunteersKetamine

Glutamate and the Neural Basis of the Subjective Effects of Ketamine: A Pharmaco-Magnetic Resonance Imaging Study

This double-blind, placebo-controlled, randomised, crossover, counterbalanced study (n=33) investigated whether ketamine-induced (20.5mg/70kg) dissociative mental state is blocked via pretreatment with the glutamate release inhibitor lamotrigine (300mg/70kg). Ketamine produced dissociative effects which corresponded to decreased activity in the ventromedial frontal cortex, including the orbitofrontal cortex and subgenual cingulate, and increased activity in mid-posterior cingulate, thalamus, and temporal cortical regions. Most of these effects were mitigated by lamotrigine, thereby indicating that the dissociative effects of ketamine are mediated by glutamate release.

Authors

  • Jamie Hallak

Published

JAMA Psychiatry
individual Study

Abstract

Context

Ketamine evokes psychosis like symptoms, and its primary action is to impair N-methyl-D-aspartate glutamate receptor neurotransmission, but it also induces secondary increases in glutamate release.

Objectives

To identify the sites of action of ketamine in inducing symptoms and to determine the role of increased glutamate release using the glutamate release inhibitor lamotrigine.

Design

Two experiments with different participants were performed using a double-blind, placebo-controlled, randomized, crossover, counterbalanced-order design. In the first experiment, the effect of intravenous ketamine hydrochloride on regional blood oxygenation level- dependent (BOLD) signal and correlated symptoms was compared with intravenous saline placebo. In the second experiment, pretreatment with lamotrigine was compared with placebo to identify which effects of ketamine are mediated by increased glutamate release.

Setting

Wellcome Trust Clinical Research Facility, Manchester, England.

Participants

Thirty-three healthy, right-handed men were recruited by advertisements.

Interventions

In experiment 1, participants were given intravenous ketamine (1-minute bolus of 0.26 mg/kg, followed by a maintenance infusion of 0.25 mg/kg/h for the remainder of the session) or placebo (0.9% saline solution). In experiment 2, participants were pretreated with 300 mg of lamotrigine or placebo and then were given the same doses of ketamine as in experiment 1. MainOutcome Measures: Regional BOLD signal changes during ketamine or placebo infusion and Brief Psychiatric Rating Scale and Clinician-Administered Dissociative States Scale scores.

Results

Ketamine induced a rapid, focal, and unexpected decrease in ventromedial frontal cortex, including orbitofrontal cortex and subgenual cingulate, which strongly predicted its dissociative effects and increased activity in mid-posterior cingulate, thalamus, and temporal cortical regions (r=0.90). Activations correlated with Brief Psychiatric Rating Scale psychosis scores. Lamotrigine pretreatment prevented many of the BOLD signal changes and the symptoms.

Conclusions

These 2 changes may underpin 2 fundamental processes of psychosis: abnormal perceptual experiences and impaired cognitive-emotional evaluation of their significance. The results are compatible with the theory that the neural and subjective effects of ketamine involve increased glutamate release.

Available with Blossom Pro

Research Summary of 'Glutamate and the Neural Basis of the Subjective Effects of Ketamine: A Pharmaco-Magnetic Resonance Imaging Study'

Introduction

Impaired signalling through N-methyl-D-aspartate (NMDA) glutamate receptors has been implicated in the pathogenesis of schizophrenia because NMDA antagonists such as phencyclidine and ketamine produce psychosislike symptoms in healthy volunteers and exacerbate symptoms in patients. Previous animal and human work indicates that NMDA blockade can both reduce inhibitory GABAergic interneuron activity and provoke secondary increases in cortical glutamate release; this glutamate surge has been linked experimentally to behavioural effects and may act via non-NMDA receptors. Positron emission tomography studies of ketamine in humans have reported frontal and sometimes anterior cingulate effects, but have not reproduced posterior cingulate, retrosplenial or hippocampal findings seen in rodents, possibly because of dose/timing differences and the temporal resolution of PET methods. Deakin and colleagues set out to map the immediate neural correlates of ketamine's subjective effects in healthy volunteers using continuous functional magnetic resonance imaging (fMRI) and to test whether those effects are mediated by increased glutamate release. They performed two double-blind, placebo-controlled, randomized, within-subject crossover experiments: first comparing intravenous ketamine with saline placebo, and second testing whether pretreatment with the glutamate-release inhibitor lamotrigine (300 mg) attenuated ketamine's behavioural and BOLD (blood oxygenation level-dependent) signal effects. The investigators used a minute-by-minute phMRI pseudoblock analysis to capture rapid, regionally specific time courses of drug effects during the early infusion period.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

References (1)

Papers cited by this study that are also in Blossom

Antidepressant effects of ketamine in depressed patients

Berman, R. M., Cappiello, A., Anand, A. et al. · Biological Psychiatry (2000)

Cited By (18)

Papers in Blossom that reference this study

Effects of a Single Dose of Ayahuasca in College Students With Harmful Alcohol Use: A Single-blind, Feasibility, Proof-of-Concept Trial

Rodrigues, L. S., Rossi, G. N., Guerra, L. T. L. et al. · Journal of Clinical Psychopharmacology (2024)

Pharmacodynamic interactions between ketamine and psychiatric medications used in the treatment of depression: a systematic review

Veraart, J. K. E., Smith-Apeldoorn, S. Y., Bakker, I. M. et al. · International Journal of Neuropsychopharmacology (2021)

The anterior cingulate cortex as a key locus of ketamine’s antidepressant action

Alexander, L., Jelen, L. A., Mehta, M. A. et al. · Neuroscience and Biobehavioral Reviews (2021)

Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials

Muthukumaraswamy, S., Forsyth, B., Lumley, T. · Expert Review of Clinical Pharmacology (2021)

Interaction of Sex and Age on the Dissociative Effects of Ketamine Action in Young Healthy Participants

Walter, M., Derntl, B., Hornung, J. et al. · Frontiers in Neuroscience (2019)

Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature

Ionescu, D. F., Felicione, J. M., Gosai, A. et al. · Harvard Review of Psychiatry (2018)

Prefrontal Connectivity and Glutamate Transmission: Relevance to Depression Pathophysiology and Ketamine Treatment

Abdallah, C. G., Averill, C. L., Salas, R. et al. · Biological Psychiatry (2017)

Show all 18 papers
Drug models of schizophrenia

Steeds, H., Carhart-Harris, R. L., Stone, J. M. · Therapeutic Advances in Psychopharmacology (2014)

Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics

Ari, A., Abdallah, C. G., Sanacora, G. et al. · Annual Review of Medicine (2014)

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs

Carhart-Harris, R. L., Leech, R., Shanahan, M. et al. · Frontiers in Human Neuroscience (2014)

Reviewing the ketamine model for schizophrenia

Frohlich, J, Van Horn, J. D. · Journal of Psychopharmacology (2013)

Glutamatergic Model Psychoses: Prediction Error, Learning, and Inference

Corlett, P. R., Honey, G. D., Krystal, J. H. et al. · Neuropsychopharmacology (2010)

User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study

Carhart-Harris, R. L., Nutt, D. J. · Journal of Substance Use (2010)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.